Jane A. Buxton mainly investigates Demography, Psychiatry, Cohort study, Public health and Confidence interval. Her Demography study combines topics from a wide range of disciplines, such as Psychological intervention, Gerontology and Cross-sectional study. In general Psychiatry study, her work on Drug often relates to the realm of Needle sharing, thereby connecting several areas of interest.
Her Cohort study research is multidisciplinary, incorporating perspectives in Incidence, Substance abuse, Hazard ratio, Prospective cohort study and Cohort. Her work deals with themes such as Lower risk and Hepatitis C, Immunology, Hepatitis, which intersect with Cohort. The Public health study which covers Emergency medicine that intersects with Intervention, Health psychology, Heroin and Fentanyl.
Her primary areas of investigation include Harm reduction, Public health, Psychiatry, Demography and Naloxone. Her Harm reduction research includes elements of Environmental health, Fentanyl, Public relations, Health psychology and Drug overdose. Her study in Public health is interdisciplinary in nature, drawing from both Immunization, Health care and Family medicine.
Hazard ratio and Cohort study is closely connected to Prospective cohort study in her research, which is encompassed under the umbrella topic of Psychiatry. Jane A. Buxton combines subjects such as Logistic regression, Epidemiology, Cross-sectional study, Confidence interval and Cohort with her study of Demography. In the field of Naloxone, her study on Opioid overdose overlaps with subjects such as Emergency medicine.
Her primary scientific interests are in Harm reduction, Naloxone, Opioid overdose, Public health and Fentanyl. Her Harm reduction study combines topics in areas such as Odds ratio, Logistic regression, Poisson regression, Demography and Harm. Her Demography research integrates issues from Syndemic, Substance abuse and Cohort.
Her Harm research also works with subjects such as
Her scientific interests lie mostly in Harm reduction, Public health, Naloxone, Fentanyl and Opioid overdose. Her Harm reduction study also includes fields such as
Her studies in Public health integrate themes in fields like Addiction and 2019-20 coronavirus outbreak. In her works, Jane A. Buxton conducts interdisciplinary research on Naloxone and Psychological intervention. Her Fentanyl study integrates concerns from other disciplines, such as Drug overdose, Heroin and Emergency medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis.
Siavash Jafari;Ray Copes;Souzan Baharlou;Mahyar Etminan.
International Journal of Infectious Diseases (2010)
Increased Burden of Illness Associated with Antimicrobial-Resistant Salmonella enterica Serotype Typhimurium Infections
Leah J. Martin;Leah J. Martin;Murray Fyfe;Kathryn Doré;Jane A. Buxton.
The Journal of Infectious Diseases (2004)
Homelessness and unstable housing associated with an increased risk of HIV and STI transmission among street-involved youth
Brandon D.L. Marshall;Thomas Kerr;Thomas Kerr;Jean A. Shoveller;Thomas L. Patterson;Thomas L. Patterson.
Health & Place (2009)
Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users.
M. J. Milloy;Thomas Kerr;Thomas Kerr;Jane Buxton;Tim Rhodes.
The Journal of Infectious Diseases (2011)
Smoking of crack cocaine as a risk factor for HIV infection among people who use injection drugs
Kora DeBeck;Thomas Kerr;Kathy Li;Benedikt Fischer.
Canadian Medical Association Journal (2009)
Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life
J. Buxton;M. White;D. Osoba.
Quality of Life Research (1998)
Minimum Alcohol Prices and Outlet Densities in British Columbia, Canada: Estimated Impacts on Alcohol-Attributable Hospital Admissions
Tim Stockwell;Jinhui Zhao;Gina Martin;Scott Macdonald.
American Journal of Public Health (2013)
The relationship between minimum alcohol prices, outlet densities and alcohol‐attributable deaths in British Columbia, 2002–09
Jinhui Zhao;Tim Stockwell;Tim Stockwell;Gina Martin;Scott Macdonald;Scott Macdonald.
Addiction (2013)
Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada.
Ashraf Amlani;Geoff McKee;Noren Khamis;Geetha Raghukumar.
Harm Reduction Journal (2015)
Homelessness as a Structural Barrier to Effective Antiretroviral Therapy Among HIV-Seropositive Illicit Drug Users in a Canadian Setting
M.-J. Milloy;Thomas Kerr;David R. Bangsberg;Jane Buxton;Jane Buxton.
Aids Patient Care and Stds (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of British Columbia
University of British Columbia
University of British Columbia
University of British Columbia
University of British Columbia
University of Victoria
Brown University
University of British Columbia
University of British Columbia
Dalhousie University
University of Western Ontario
École Polytechnique Fédérale de Lausanne
University of Ioannina
University of Virginia
Norwegian University of Life Sciences
Southern Illinois University School of Medicine
Washington University in St. Louis
Agency for Science, Technology and Research
Lancaster University
Karolinska Institute
The University of Texas MD Anderson Cancer Center
National Institutes of Health
Icahn School of Medicine at Mount Sinai
University of Maryland, College Park
Research Institute in Astrophysics and Planetology
Grenoble Alpes University